Anand Sampath's most recent trade in Masimo Corp was a trade of 6,840 Restricted Stock Units done . Disclosure was reported to the exchange on March 6, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Masimo Corp | Anand Sampath | EVP, Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2026 | 6,840 | 6,840 | - | - | Restricted Stock Units | |
| Masimo Corp | Anand Sampath | EVP, Ops & Clinical Research | Exercise or conversion of derivative security received from the company (such as an option) at price $ 37.84 per share. | 28 Jan 2026 | 30,000 | 59,589 (0%) | 0% | 37.8 | 1,135,200 | Common Stock |
| Masimo Corp | Anand Sampath | EVP, Ops & Clinical Research | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Jan 2026 | 30,000 | 0 | - | - | Non-Qualified Stock Option (Right to Buy) | |
| Masimo Corp | Anand Sampath | EVP, Ops & Clinical Research | Sale of securities on an exchange or to another person at price $ 136.56 per share. | 28 Jan 2026 | 11,924 | 47,665 (0%) | 0% | 136.6 | 1,628,341 | Common Stock |
| Masimo Corp | Anand Sampath | EVP, Ops & Clinical Research | Sale of securities on an exchange or to another person at price $ 137.22 per share. | 28 Jan 2026 | 6,560 | 41,105 (0%) | 0% | 137.2 | 900,163 | Common Stock |
| Masimo Corp | Anand Sampath | EVP, Ops & Clinical Research | Sale of securities on an exchange or to another person at price $ 138.09 per share. | 28 Jan 2026 | 196 | 40,909 (0%) | 0% | 138.1 | 27,066 | Common Stock |